News|Videos|August 14, 2026

How New “Shared Clinical Decision Making” Vaccine Category Will Likely Increase Children’s Disease

In the second part of the interview with Sharon Nachman, MD, she touches upon how the administration’s shared clinical decision-making category related to childhood vaccines will affect the hepatitis B and rotavirus vaccines and the expectations there will be subsequent disease increases.

One of the newer elements within the childhood vaccine schedule is the shared clinical decision-making category. This category was set-up by the leadership of the current Advisory Committee on Immunization Practices (ACIP) and Health and Human Services (HHS) Secretary Robert F. Kennedy as a way to limit childhood vaccines. The vaccine schedule was front and center this week, when President Trump signed an executive order around it, offering directives that mirrored ACIP’s and Kennedy’s wishes.

Related to this article

Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
A new study in infants challenges the long-standing belief about the pathogen’s effects in the youngest pediatric population. Senior author Joseph Zackular, PhD, provides insights around his work including how it reshapes gut development and offers potential intervention strategies to shield neonates.
How The Food Safety Surveillance Infrastructure Works in the US
In the first episode of our new series looking at the food safety network, Lynette Johnston, PhD, offers insights into how the federal government surveillance infrastructure operates and how epidemiologists serve as food detectives in determining bacterial pathogens and potential foodborne outbreaks.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.